Bedford, MA- November 13, 2023– Vox Biomedical is excited to announce its relocation to a new, larger facility located at 4 Preston Ct. This move represents a significant milestone in the company’s growth and will support its continued commitment to innovation and research & development.
The new facility is located at Bedford’s Science and Technology District and close to several leading life science and biotech companies. The new location provides expanded office and laboratory spaces with the option to further expand as the company anticipates future growth.
Recently, Vox has expanded its portfolio program with the development of an innovative artificial intelligence-based chemical identification library for the characterization of volatile organic compounds (VOCs). This will enable biomarker discovery for diseases a less resource intensive process expediting the discovery and confirmation of biomarkers for early-stage disease detection, ultimately saving lives.
Vox Biomedical continues to make progress in the development of innovative spectroscopy-based products for biomedical, industrial, and scientific applications.
Contact:
Arash Aslani
VP/GM
781-301-3893